J0278 HCPCS Level II code: Injection, amikacin sulfate, 100 mg
J0278 is the HCPCS code for “Injection, amikacin sulfate, 100 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0278Injection, amikacin sulfate, 100 mg
Short description: Amikacin sulfate injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J0278 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2006
Where J0278 sits
- 1J codesDrugs administered other than orally
- 2Active code J0278Injection, amikacin sulfate, 100 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0278 mean?
J0278 is the HCPCS code for “Injection, amikacin sulfate, 100 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0278?
CMS lists J0278’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0278
All J codesJ0225Injection, vutrisiran, 1 mgJ0248Injection, remdesivir, 1 mgJ0256Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mgJ0257Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mgJ0270Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0275Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)J0280Injection, aminophyllin, up to 250 mgJ0281Injection, aminocaproic acid, 1 gramJ0282Injection, amiodarone hydrochloride, 30 mgJ0283Injection, amiodarone hydrochloride (nexterone), 30 mgJ0285Injection, amphotericin b, 50 mgJ0287Injection, amphotericin b lipid complex, 10 mg